Human Health Holdings Ltd. (HK:1419)
:1419
Top Page
Human Health Holdings Ltd.
(1419)
Select Model
Select Model
Rating:52Neutral
Price Target:
HK$1.00
▲(25.00% Upside)
Action:N/ADate:07/19/25
The overall stock score of 52 for HK:1419 is primarily driven by weak financial performance (score: 43, weight: 0.5), with significant concerns in revenue decline (-41%) and negative cash flow (-28.2M) overshadowing a stable balance sheet. Technical analysis (score: 60, weight: 0.3) offers mild optimism with an upward price trend, while valuation (score: 65, weight: 0.2) is reasonable due to a fair P/E ratio and attractive dividend yield. Investors should remain cautious given the financial challenges.
Positive Factors
Low Leverage
The company's low leverage indicates a solid financial foundation, reducing risk and providing flexibility to navigate financial challenges.
Negative Factors
Declining Revenue
A significant decline in revenue indicates potential loss of market share or demand, challenging the company's ability to sustain operations.
Read all positive and negative factors
Positive Factors
Negative Factors
Low Leverage
The company's low leverage indicates a solid financial foundation, reducing risk and providing flexibility to navigate financial challenges.
Read all positive factors
Human Health Holdings Ltd. (1419) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$311.23M
Dividend Yield3.75%
Average Volume (3M)631.27K
Price to Earnings (P/E)4.1
Beta (1Y)0.31
Revenue Growth9.07%
EPS Growth8.95%
CountryHK
Employees388
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)0.05
Shares Outstanding379,552,220
10 Day Avg. Volume387,000
30 Day Avg. Volume631,266
Financial Highlights & Ratios
PEG Ratio1.34
Price to Book (P/B)0.41
Price to Sales (P/S)0.49
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Human Health Holdings Ltd. Business Overview & Revenue Model
Company Description
Human Health Holdings Limited, an investment holding company, provides healthcare services in Hong Kong. The company offers general practice services, including general consultation, diagnostics and preventative health, minor procedure, vaccinatio...
How the Company Makes Money
Human Health Holdings Ltd. generates revenue through its extensive network of medical centers by providing medical consultations, diagnostic testing, and health assessment services. The company's key revenue streams include fees for medical consul...
Human Health Holdings Ltd. Financial Statement Overview
Summary
Income Statement
35
Negative
Balance Sheet
75
Positive
Cash Flow
20
Very Negative
| Breakdown | TTM | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 670.99M | 644.43M | 590.82M | 1.00B | 1.12B | 654.71M |
| Gross Profit | 274.24M | 296.57M | 269.85M | 593.24M | 659.68M | 376.69M |
| EBITDA | 57.00M | 52.32M | 104.06M | 323.46M | 513.25M | 238.36M |
| Net Income | 27.77M | 26.34M | 24.19M | 180.84M | 375.31M | 144.45M |
Balance Sheet | ||||||
| Total Assets | 1.05B | 1.07B | 1.06B | 1.26B | 1.16B | 612.39M |
| Cash, Cash Equivalents and Short-Term Investments | 475.56M | 439.90M | 489.58M | 641.26M | 270.33M | 145.26M |
| Total Debt | 174.22M | 134.54M | 146.46M | 182.49M | 188.47M | 67.08M |
| Total Liabilities | 266.99M | 290.22M | 289.71M | 455.27M | 416.67M | 202.26M |
| Stockholders Equity | 786.26M | 781.75M | 766.67M | 808.22M | 741.95M | 410.13M |
Cash Flow | ||||||
| Free Cash Flow | 66.03M | 0.00 | -28.17M | 580.24M | 219.30M | 71.44M |
| Operating Cash Flow | 68.45M | 0.00 | 11.34M | 664.26M | 295.81M | 85.49M |
| Investing Cash Flow | -13.12M | 0.00 | -47.63M | -335.34M | -203.22M | -4.77M |
| Financing Cash Flow | -32.49M | 0.00 | -122.66M | -178.28M | -67.45M | -59.30M |
Human Health Holdings Ltd. Technical Analysis
Negative
0.80
Price Trends
0.82
Positive
0.81
Positive
0.87
Negative
Market Momentum
<0.01
Positive
48.22
Neutral
40.00
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1419, the sentiment is Negative. The current price of 0.8 is below the 20-day moving average (MA) of 0.83, below the 50-day MA of 0.82, and below the 200-day MA of 0.87, indicating a neutral trend. The MACD of <0.01 indicates Positive momentum. The RSI at 48.22 is Neutral, neither overbought nor oversold. The STOCH value of 40.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1419.
Human Health Holdings Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$356.42M | 4.98 | 4.28% | 7.10% | -2.88% | -22.83% | |
71 Outperform | HK$678.82M | 3.30 | 5.29% | 9.14% | 0.47% | 50.46% | |
64 Neutral | HK$160.98M | 5.31 | 6.92% | 8.00% | -21.50% | -43.25% | |
55 Neutral | HK$475.00M | 4.08 | 5.27% | 4.49% | 20.85% | -66.81% | |
52 Neutral | HK$311.23M | 4.11 | 3.54% | 3.75% | 9.07% | 8.95% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
42 Neutral | HK$124.00M | -20.58 | -1449.22% | ― | -30.45% | -734.38% |
* Healthcare Sector Average
HK:1419
Human Health Holdings Ltd.
0.82
0.11
15.49%
HK:8143
Good Fellow Healthcare Holdings Limited
0.11
0.06
100.00%
HK:2189
Kato (Hong Kong) Holdings Ltd.
0.48
0.02
5.56%
HK:2293
Bamboos Health Care Holdings Ltd
0.40
-0.14
-25.93%
HK:3689
Guangdong Kanghua Healthcare Co., Ltd. Class H
2.03
0.21
11.54%
HK:0722
UMP Healthcare Holdings Limited
0.45
0.07
19.30%
Human Health Holdings Ltd. Corporate Events
Human Health Holdings Secures Shareholder Approval for Key Resolutions at AGM
Dec 10, 2025
Human Health Holdings Limited announced that all resolutions proposed during its Annual General Meeting on December 10, 2025, were approved by shareholders. The resolutions included the adoption of financial statements, declaration of a final divi...
Human Health Holdings Ltd. Announces Annual General Meeting and Key Resolutions
Oct 30, 2025
Human Health Holdings Ltd. has announced its upcoming annual general meeting scheduled for December 10, 2025, in Hong Kong. Key agenda items include the adoption of financial statements, declaration of a final dividend, appointment of Ernst Young...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.